Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
non-coding rna
repetitive dna sequences
5
×
tc
biotechnology
crispr
1963 births
american biochemists
american women scientists
berkeley college of chemistry faculty
bio
biological engineering
biology
broad institute
crystallographers
emerging technologies
engineering disciplines
genetic engineering
genetics or genomics research institutions
harvard medical school
harvard university
harvard university alumni
health
howard hughes medical investigators
laboratories in the united states
living people
massachusetts
massachusetts institute of technology
members of the national academy of medicine
members of the united states national academy of sciences
molecular biology
non-profit organizations based in massachusetts
organizations based in cambridge
research institutes in the united states
university of california
women biochemists
yale department of molecular biophysics & biochemistry faculty
$250 million
1861 establishments in massachusetts
1987 establishments in texas
3d printing
What
cas
5
×
crispr
berkeley
broad
institute
read
technology
today
belongs
california
doudna
editing
enzyme
gene
genetic
harvard
inventor
jennifer
judge
patent
rules
think
university
using
ability
academy
acts
actually
afternoon
alexandria
allowing
antibiotic
antibiotics
applications
art
based
belong
berkeley’s
biosciences
came
Language
Current search:
cas
×
photo
×
" repetitive dna sequences "
×
@techcrunch.com
7 years ago
CRISPR pioneer Jennifer Doudna shines hope on the future of genetic modification at SXSW
@techcrunch.com
7 years ago
Crunch Report | Judge Rules CRISPR-Cas9 Belongs to Broad Institute
@techcrunch.com
7 years ago
CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans
@techcrunch.com
7 years ago
Judge rules CRISPR-Cas9 patents belong to Broad Institute of Harvard and MIT
@techcrunch.com
7 years ago
Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis